Those with heavy metals poisoning have usually exhausted a number of therapies and remedies in the course of searching for wellness.  The timeframe for ridding the body of heavy metals can extend into years and it is not unusual to use a lot of trial and error for deleting it from the body.  The horizon often looks dismal, but there is a remedy in FDA trials that brings great hope to the long-term, extensive and painful remedies available for detoxing heavy metals.

The product is NBMI which has had several name changes and was known and Irminix, OSR and a few other names.  It is all the same product and it has those sick from metals poisoning waiting to be able to access it.

FDA access has been a lengthy process which has driven many to use counterfeit products.  These products made by others are sold on line and simply are not NBMI.    In many cases the counterfeit manufacturer has the consumer sign a waiver stating they are aware that the product is not for human or animal consumption.  Actual NMBI will have no such warning.

It is possible to access NBMI via the FDA process, but availability depends on the regulations in your area.  In some areas it is very easy and in others it can take time.    

​We now have another possible route to obtaining this product that clears metals without the usual side effects or danger to the body.  In May of 2018 the Right to Try Act was signed in the United States.  It gives critically ill patients the right to try drugs that are in trials within the Food and Drug Administration.  Thirty seven states have adopted the law on a state level.  With or without state adoption of the Right to Try Act you are able to utilize the law, as state approval is not necessary.

Because the law is new not everything is known about how it will function or what will be approved.  Things that are known for sure are:

• Although there may be a charge for obtaining the drug, the drug itself will be free.
• You must have a life threatening condition.
• You must have exhausted other options.
• You must not be able to qualify for trials as certified by a doctor.
• You must have informed consent of any potential risks.

In terms of the qualifying conditions, those poisoned strongly believe their lives are at risk.  Most have exhausted many options, but clearly most have side effects that make long term use a risky proposition.  There is no certainty as to how the FDA will interface with this law, but the opportunity to apply under the Right to Try Act is available.

Emeramed’s NBMI was on the market several years ago as a dietary antioxidant.  It proved a very effective chelator of metals with an affinity for mercury.  It crosses the blood brain barrier and clears the body of metals without painful side effects.

Once NMBI chelates to metal, it becomes inert and unable to harm the body.  It will not drop the metal before it exits the body which prevents it from reabsorbing into tissue, organs, bones and brain.  The chelated metal exits the body via the colon and not the kidneys, thereby preventing damage to organs.  There are no known side effects to this product.

The focus of testing NBMI has been done with mercury.  All results are positive for it's ability to chelate and remove the metal.  It manages other metals as well, but has an affinity for removing mercury first.  Because it crosses the blood-brain barrier, it clears the brain of metal and has shown success with Alzheimer’s patients, although it is not yet in trials for that particular use.  Another area of success is COPD which can be an accumulation of cadmium in the lungs.  Patients who have used NBMI for this purpose have experienced great improvement in very short time periods.

The US Army is considering testing of NMBI on mustard gas toxicity.  The governments of Ecuador and Columbia have successfully used it on gold miners who use mercury to separate materials while mining.  The success rate was overwhelming.

Currently NBMI is not available in the US without special authorization from the FDA.  Some countries have allowed its use and others provide very simple access to NBMI.  The links below will take you to the application form for Emeramed’s site to the FDA’s Compassionate Use application and another to the federal application for the Right to Try Act.


Emeramed
emeramed.com/early-access/

Right to Try Act  
righttotry.org/rtt-faq/

Dr. Boyd Haley's Emeramed is available for those contaminated by mercury and other heavy metals.  As of this date, it is available for compassionate use only.   The application process can be lengthly for some countries and in others it is very simple or unnecessary.  The product is currently provided for free with a fee of $750 for application  processing.

If you have not heard of Emeramed's product, which is NBMI in America, it is a very successful mercury chelator that is anticipating FDA approval soon.  It has been on the market as a supplement and it has a proven track record of removing mercury without the side effects of other methods.   

Emeramed Background Information as of May 2018  
Emeramed Ltd. is an Irish biotech company with subsidiaries in the USA and Sweden.  They have produced a metals chelator and antioxidant currently known as NMBI.  This product was formally distributed as a dietary supplement from 2008-2010 as OSR.  It has also been known as Irminix and Emeramide. 

NBMI is a metals chelator that should revolutionize the process of detoxing metals from the body.  The product will bind and remove toxic metals such as mercury, lead, cadmium, arsenic, free iron, copper and zinc.  It is also useful treating oxidative stress. 

Unique Among Metals Chelator
NBMI is highly lipophilic, or fat soluble.  To the consumer, that means that it has the ability to pass thru cell membranes and will also cross the blood-brain barrier to clear the brain of metals.  This is a very important part of the detoxification process and of vital importance in finding wellness.

NMBI is not known to have any adverse side effects.  Those who detox with more common methods know the vast number of side effects that can be painful, dangerous and harmful to the body.    NMBI has none of these and in addition it does not deplete the body of elements that are essential to the body.  It creates no damage to organs as it renders the metal inert and allows it to pass through the colon.

Currently the drug is only offered for compassionate use by most governing authorities.  If you are interested in a copy of the forms to apply for early access, please see the link below.

Current Protocol
The company is mandated to offer only a 14 day treatment of 300mg per day.  The treatment length was designed to mimic the testing protocol used in Phase 1 and 2 of clinical trials.  The amount needed will ultimately vary for patients, depending on the amount of exposure and the amount of stored metals in the body.  There is no guarantee that doses allowed will be refilled.  From past experience, the results show that even 14 days of use provides positive results in patients.

Early Access Program Information 
Early access requires application to the company.  If the application is accepted, your physician or dentist will be provided the documents necessary for application to the regulatory authority of your country.  

There is no approval necessary for New Zealand.  Austria and Germany are fairly liberal, with the USA being most difficult approval to obtain.​

Step One of the process is to complete and return the application form to Emeramed.  A copy of the application form to Emeramed can be obtained at the link below.

emeramed.com/early-access/

  
There is no safe level of lead in a body, yet the FDA
allows it in dinnerware, food, cosmetics
and many consumer goods.

Although we are more adept at recognizing the problem in children, adults are also highly susceptible.  
Because lead poisoning is easily misdiagnosed,
​knowing the symptoms is your best defense.



​